| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |